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Edward O’Leary, MD
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OBJECTIVES We sought to determine how successful pulse inversion Doppler (PID) imaging would be in
detecting myocardial perfusion defects during dobutamine stress echocardiography.
BACKGROUND By transmitting multiple pulses of alternating polarity (PID) at a low mechanical index,
myocardial contrast enhancement from intravenously injected microbubbles can be detected
using real-time frame rates.
METHODS Pulse inversion Doppler imaging was performed in 117 patients during dobutamine stress
echocardiography by using an intravenous bolus of a perfluorocarbon-filled, albumin-
(Optison: n 5 98) or liposome- (Definity: n 5 19) encapsulated microbubble and a
mechanical index of ,0.3. The visual identification of myocardial contrast defects and wall
motion abnormalities was determined by blinded review. Forty of the patients had
quantitative angiography (QA) performed to correlate territorial contrast defects with stenosis
diameter .50%.
RESULTS There was a virtual absence of signal from the myocardium before contrast injections in all
patients. Bright myocardial opacification at peak stress was observed in at least one coronary
artery territory at frame rates up to 25 Hz in 114 of the 117 patients during dobutamine stress
echocardiography. Regional myocardial contrast defects at peak stress were observed in all 30
patients with .50% stenosis in at least one vessel (13 with single-vessel and 17 with
multivessel disease). Contrast defects were observed in 17 territories subtended by .50%
diameter stenosis that had normal wall motion at peak stress. Overall agreement between QA
and myocardial contrast enhancement on a territorial basis was 83%, as compared with 72%
for wall motion.
CONCLUSIONS Pulse inversion Doppler imaging allows the detection of myocardial perfusion abnormalities
in real-time during stress echocardiography and will further add to the quality and sensitivity
of this test. (J Am Coll Cardiol 2001;37:748–53) © 2001 by the American College of
Cardiology
Recent discoveries have shown that myocardial contrast
enhancement after intravenous perfluorocarbon-containing
microbubbles can be achieved in real-time with harmonic
imaging at a low mechanical index. Unlike the myocardial
contrast achieved with intermittent imaging at higher me-
chanical indexes (1–3), a lower index reduces microbubble
destruction and permits the detection of harmonic myocar-
dial contrast enhancement at frame rates of 10 to 20 Hz
(4,5).
A lower mechanical index can also be used with pulse
inversion Doppler (PID) imaging by examining nonlinear
scatter in the Doppler frequency domain instead of the
radiofrequency domain (6). With PID imaging, three to five
ultrasound pulses are transmitted into the tissue, with each
sequential pulse containing the opposite configuration of
the preceding pulse. In vitro studies have demonstrated a
significantly greater intensity of the contrast signal obtained
with PID imaging as compared with harmonic imaging (6).
In addition, there is no linear scatter overlap in the Doppler
frequency domain; thus, enhanced real-time myocardial
contrast enhancement can be achieved with reduced back-
ground tissue interference (7). We hypothesized that PID
imaging would be clinically useful during dobutamine stress
testing, where both wall motion and perfusion are important
in detecting angiographically significant coronary artery
disease (8).
METHODS
The study involved 117 consecutive patients undergoing
dobutamine stress echocardiography. The mean age of the
patients was 62 6 12 years (60 women). The studies were
done in patients who had an intermediate pretest probability
of significant coronary artery disease based on cardiac risk
factors and clinical presentation (9). Forty-eight of the
patients had atypical chest pain with risk factors, 38 had
typical chest pain and 31 had multiple risk factors without
chest discomfort. Thirty-three patients (28%) had diabetes,
78 (67%) had hypertension, 25 (21%) had a history of
myocardial infarction and 34 (29%) had previous coronary
artery bypass graft surgery or percutaneous revascularization.
The contrast agents used for the study were either a
‘perfluorocarbon-containing albumin-coated microbubble
(Optison, Mallinckrodt, St. Louis, Missouri) or a lipid-
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encapsulated perfluoropropane-filled microbubble (Definity
by DuPont Pharmaceuticals, Wilmington, Delaware). Left
ventricular ejection fraction was calculated using an adap-
tation of the cylinder hemi-ellipsoid formula, as described
by Vuille and Weyman (10), and was .40% in all patients.
The entire study was approved by the Institutional Review
Board at the University of Nebraska Medical Center.
Pulse inversion Doppler imaging set-up. Pulse inversion
Doppler imaging was performed using an HDI 5000
scanner (Advanced Technology Laboratories, Bothell,
Washington) and a 1.7-MHz transducer. The mechanical
index was set between 0.12 and 0.18 for all Optison studies.
A slightly higher mechanical index of 0.24 to 0.26 was
chosen for Definity, based on previous observations in
humans showing lesser degrees of attenuation and greater
myocardial contrast at this mechanical index as compared
with the range 0.12 to 0.18 (11). Time gain compensation,
scan line density and frame rates for both agents are
displayed in Table 1.
Dobutamine stress protocols. Baseline contrast-enhanced
images were obtained in all three apical windows (four-
chamber, two-chamber and long-axis views) after either a
0.3-ml bolus injection of Optison or a 0.15-ml injection of
Definity. Dobutamine was then infused in 3- to 5-min
stages of 5, 10, 20, 30 and, if necessary, 40 m/kg per min.
Atropine (up to 2 mg) was added to achieve .85%
predicted maximal heart rate. Repeat contrast-enhanced
images were obtained during the peak dobutamine infusion
using the same apical views that were acquired under rest
conditions, as well as the same doses of ultrasound contrast
agent. The rest and peak dobutamine contrast-enhanced
images were displayed on a quad screen format for blinded
review of contrast enhancement. In 55 patients, contrast
enhancement during an earlier low dose of dobutamine (10
to 20 m/kg per min) was also assessed.
Analysis of contrast enhancement and wall motion. One
independent reviewer (F.X.), who had no knowledge of the
patients’ history, angiographic findings or other clinical
data, examined the videotape and digitized images of all
studies and graded both contrast enhancement and the
location of any defects. Myocardial contrast enhancement
and wall motion were evaluated according to segments and
coronary artery distribution. Anteroseptal, apical and ante-
rior segments were considered to be in the left anterior
descending coronary artery (LAD) distribution, lateral seg-
ments in the left circumflex artery (LCx) and inferior
segments in the right coronary artery (RCA) territory. The
posterior wall was considered an overlap region, which was
assigned to either the LCx or RCA distribution, as deter-
mined by quantitative angiography (QA). The period at
which a contrast defect appeared after the bolus injection of
contrast agent was also calculated from videotape review.
The time (s) of when a defect first appeared in relation to
the peak period of contrast enhancement until it disap-
peared from all segments was measured for all visually
discernible defects.
The degree of myocardial contrast enhancement was
graded in the basal, mid and distal segments of each wall, as
well as the apex, by using the following scoring criteria: 0 5
no enhancement; 11 5 mild enhancement; 21 5 bright
contrast enhancement. If a score of 0 or 11 was given to a
segment, the reviewer determined whether the lack of
enhancement was due to attenuation or a contrast defect. A
contrast defect was considered present when two contiguous
segments failed to exhibit contrast enhancement as com-
pared with other segments at the same depth in the same
view, and by comparing the contrast defect with side by side
baseline images. Attenuation from contrast or lung inter-
ference was considered present if the segment could not be
visualized or was not distinguishable from surrounding
tissue.
A wall motion abnormality consistent with ischemia was
considered present whenever hypokinesia, akinesia or dys-
kinesia was observed only at peak stress. A segment or
territory was scored as an infarction whenever hypokinesia,
akinesia or dyskinesia was present at rest and did not change
during the low dose or peak dobutamine stress imaging.
Quantitative angiography. Quantitative measurements
were made by an experienced interventional cardiologist
(E.O.) using a hand-held electronic caliper (Tesa S.A.,
Renens, Switzerland) operated with custom-developed PC
software (12). Measurements were expressed as the percent
diameter narrowing using the diameter of the nearest
normal-appearing region as a reference. Coronary artery
narrowings of .50% and 70% diameter in the native or
graft vessel were both used as cut-off values. The interven-
tional cardiologist also estimated the coronary artery terri-
tory subtended by each stenosis with PID imaging or wall
motion.
Abbreviations and Acronyms
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
PID 5 pulse inversion Doppler
QA 5 quantitative angiography
RCA 5 right coronary artery
Table 1. Instrumentation Settings for Pulse Inversion Doppler
Imaging With Intravenous Optison and Definity
Pulse Inversion Doppler Imaging
Optison Definity
Transducer frequency (MHz) 1.55–1.65 1.55–1.65
Mechanical index 0.12–0.18 0.24–0.26
Pulse repetition frequency (Hz) 1,500 2,000
Scan line density Low Low
Sensitivity Medium Medium
Focus (cm) 10–13 10–13
Potentiometers (dB) Maximal time gain
compensation for
all but top two
55–59
Color gain 55% 50%
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Statistical analysis. Kappa values were calculated to com-
pare segmental and territorial contrast enhancement and
wall thickening with angiographic measurements. Interob-
server agreement was also calculated by having a second
independent reviewer analyze the segmental and territorial
wall motion and contrast enhancement in 45 patients.
Contingency tables were used to compare differences in
contrast enhancement or concordance with angiography
when using Definity versus Optison.
RESULTS
Assessment of segmental contrast enhancement with
pulse inversion Doppler imaging. Using the presets dis-
played in Table 1, bright 21 myocardial contrast was
observed in at least two contiguous segments of one coro-
nary artery territory in 109 of the patients (93%) under rest
conditions and in 114 patients (97%) at peak dobutamine
stress. Overall, attenuation was considered present in 335
(16%) of the 2,073 segments, with 304 of these (91%) in
basal segments. The incidence of segmental attenuation was
higher with intravenous Definity (24% of the total seg-
ments) than with Optison (16% of total segments; p ,
0.001).
Sixty of the patients were considered to have normal
myocardial contrast enhancement in all coronary artery
territories at rest and at peak dobutamine stress, whereas 57
patients (total of 83 coronary artery territories) had a
contrast defect at peak dobutamine stress (75 inducible, 8
fixed). Wall motion and PID imaging were in agreement in
91% of the territories at peak stress (kappa 0.70). However,
wall motion was considered normal in 31 (37%) of the 83
coronary artery territories with contrast defects.
Eleven patients (9%) had rest wall motion abnormalities.
Seven of these patients did not exhibit an improvement in
wall motion during low dose dobutamine infusion, and
therefore were classified as having an infarction. Four
patients improved during low dose dobutamine, but had
deterioration in wall motion at peak stress, and thus were
classified as having ischemia. Ten of these 11 patients
exhibited rest contrast defects by PID imaging in the
regions where wall motion was abnormal.
Angiographic results in patients with contrast defects on
PID imaging. Ten of the 40 patients had ,50% diameter
stenoses in all vessels. Maximal percent diameter stenosis
was between 20% and 45% in six of these patients, and in
these patients both wall motion and myocardial contrast
with PID imaging were normal in five. In four patients, the
percent diameter stenosis was ,10% in all vessels. Pulse
inversion Doppler imaging was abnormal in all four of these
patients and wall motion was abnormal in three at peak
stress. These false positive contrast defects were in the
anteroseptal and apical regions in two patients; in the
inferior, lateral and posterior regions in one patient; and in
the lateral wall in one patient.
Thirty patients undergoing angiography had significant
coronary artery stenosis (13 with single-vessel and 17 with
multivessel disease). Contrast defects with PID imaging
were visually evident in at least one territory at peak stress in
all patients. The time of first visualization of these contrast
defects, however, was after the peak period of myocardial
contrast. The mean time to the first visual appearance of an
inducible contrast defect was 4 6 3 s (range 0 to 10) after
peak stress. An example of the delayed appearance of an
inducible contrast defect is demonstrated in Figure 1,
showing the PID image of a patient who had an inducible
anteroseptal and apical wall motion abnormality during
dobutamine stress. At the peak period of left ventricular
cavity contrast (Fig. 1, top panel), myocardial contrast
enhancement is transiently evident. At 5 s after peak
myocardial contrast enhancement (Fig. 1, bottom panel),
the contrast defect appears. In comparison, in the seven
coronary territories that were considered as having infarc-
tion, on the basis of rest and low dose dobutamine wall
motion responses, all but one exhibited contrast defects,
even at the peak period of contrast enhancement. In
coronary artery territories that were subtended by ,50%
diameter stenosis, contrast enhancement persisted for 17 6
6 s (range 10 to 27 s) after peak enhancement.
In the 30 patients with angiographic disease, there were a
total of 55 coronary artery territories supplied by .50%
diameter stenosis and 40 territories supplied by .70%
diameter stenosis. Contrast defects at peak stress were
observed in 46 (84%) of the 55 territories supplied by .50%
diameter stenosis and in 34 (85%) of the 40 territories
supplied by .70% diameter stenosis. Figures 1 through 3
demonstrate inducible perfusion defects in the LAD (Fig.
1), LCx (Fig. 2) and RCA (Fig. 3) territories of patients
with .50% diameter stenosis supplying each territory. In
each of these cases, there were no wall motion abnormalities
at peak stress.
Using the 50% diameter cut-off value, overall concor-
dance between myocardial contrast and QA on a territorial
basis was 83% (kappa 0.65). The overall concordance
Figure 1. An example of an inducible anteroseptal contrast defect on PID
imaging after intravenous Optison (apical three-chamber size). Note that
at peak myocardial contrast (PMC) enhancement, there was no contrast
defect. At 5 s after PMC, a defect was first observed (arrows). ED 5
end-diastole; ES 5 end-systole.
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between wall motion and angiography was 72% (p 5 0.07
vs. PID agreement with angiography). The PID imaging
results were in agreement with the QA results in 83% of the
LAD territories, 80% of the RCA territories and 85% of the
LCx territories. In comparison, wall motion was in agree-
ment with QA in 68% of the LAD territories. In the 22
territories that exhibited abnormal contrast enhancement at
peak stress, but were still considered to have normal wall
motion, 17 (77%) had .50% coronary stenosis subtending
the territory. There was no differences in the rate–pressure
product achieved between patients who had inducible con-
trast defects without wall motion abnormalities (21,500 6
4,200) and those with both contrast defects and wall motion
abnormalities (19,900 6 3,500), as compared with patients
who had both inducible wall motion abnormalities and
contrast defects (n 5 22 territories in 16 patients). There
was also no difference in the percent diameter stenosis
subtending the coronary artery territory between the two
groups (73 6 14% vs. 79 6 17%; p 5 0.34). However,
contrast defects were observed before the development of
wall motion abnormalities. In the 22 patients who under-
went QA and who had both inducible wall motion abnor-
malities and contrast defects at peak stress, 12 (55%) had
contrast defects during low dose dobutamine infusion (Fig. 4).
Interobserver agreement. There was 84% agreement be-
tween the reviewers who scored contrast enhancement
(kappa 0.63), and 91% agreement (kappa 0.64) between
reviewers who scored wall motion.
DISCUSSION
In this study, we demonstrated that the simultaneous
assessment of myocardial perfusion and wall thickening
could be performed with PID imaging. The advantages of
PID imaging over B-mode harmonic imaging include the
virtual elimination in background signal noise before injec-
tion (demonstrated in Fig. 4) and the enhanced nonlinear
backscatter produced by the pulse inversion waveform at
this very low mechanical index. In .90% of the patients in
this study, we observed bright myocardial opacification from
small intravenous bolus injections of either Optison or
Definity.
Rationale for a low mechanical index with PID imaging.
Regardless of the imaging technique or location of micro-
bubble injection, myocardial contrast enhancement from
microbubbles has been shown to reflect myocardial blood
volume (13,14). Myocardial blood volume distal to .50%
diameter coronary stenosis is reduced during pharmacologic
stress, resulting in the appearance of contrast defects (3).
The regional location of contrast defects observed during
pharmacologic stress after intravenous bolus injections of
microbubbles in humans is closely correlated with radionu-
clide uptake (3,4).
Until recently, detection of these defects has required
intermittent imaging to reduce microbubble destruction.
Figure 2. An example of an inducible lateral wall perfusion defect (arrows;
bottom panel) in the apical four-chamber view from a patient with
significant left circumflex coronary artery (LCx) stenosis at angiography.
The rest images from end-diastole to end-systole obtained with pulse
inversion Doppler (PID) imaging are shown on the top panel. ED 5
end-diastole; ES 5 end-systole.
Figure 3. An example of an inducible inferior myocardial contrast defect
(arrows) on pulse inversion Doppler (PID) imaging in the apical two-
chamber view after intravenous Optison administration in a patient with
.50% diameter stenosis in the right coronary artery (RCA). Wall motion
was considered normal in this patient both at rest and during stress.
Figure 4. An example of the early appearance of an apical perfusion defect
(arrows) in the apical four-chamber view after intravenous (IV) Optison
administration during low dose dobutamine echocardiography. Rest con-
trast enhancement is shown in the right top panel, low dose dobutamine
images in the left bottom panel and peak images in the right bottom
panel. Both wall motion and contrast enhancement were abnormal in the
apex at peak dobutamine stress (right bottom panel). This patient had
significant left anterior descending coronary artery (LAD) stenoses on
quantitative angiography (QA). The left upper panel is before ultrasound
contrast under baseline conditions.
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More recent investigations in humans have shown that
nonlinear scatter from microbubbles can be observed at
faster frame rates if a mechanical index of ,0.4 is used
(4,5,15). These initial studies were performed with B-mode
harmonic imaging, during which linear echoes from tissue
at baseline often mask or interfere with the nonlinear scatter
from microbubbles. This interference from linear echoes
was not present with PID imaging, because in this setting,
wall filters can be used to completely eliminate any linear
scatter from tissue (6). Furthermore, in vitro studies have
demonstrated that the nonlinear response from micro-
bubbles, when using PID imaging, is .10 dB higher than
the response with harmonic imaging (7). Therefore, we
observed both bright myocardial contrast from intravenous
Optison or Definity and significantly less background tissue
interference.
Improved concordance with QA. Our study demon-
strated that the addition of PID imaging to dobutamine
stress testing may improve the sensitivity of detecting
coronary artery disease. Although wall motion and contrast
enhancement were in agreement in 90% of the coronary
artery territories, there were a significant number of terri-
tories subtended by .50% diameter stenosis, which exhib-
ited contrast defects despite normal wall motion. Similar
findings have been observed with radionuclide single-
photon emission computed tomographic studies comparing
wall motion and perfusion with angiography during dobut-
amine stress (8). The patients who exhibited abnormal
contrast enhancement but normal wall motion did not have
lower rate–pressure products or lesser degrees of stenosis
severity. The most likely explanation for the improved
concordance observed with perfusion imaging is that the
threshold for inducing a perfusion defect is lower. We
observed perfusion defects during the lower dose dobut-
amine stages in 55% of the patients who had both wall
motion abnormalities and perfusion defects at peak stress,
which indicates that the target heart rate required to detect
significant coronary artery disease with dobutamine perfu-
sion imaging is lower.
Potential limitations of interpretation of PID imaging.
Although we could easily identify perfusion defects in
real-time with PID imaging, the dynamic range of the
technique is a potential limitation. This was most evident
with bolus injections during dobutamine stress, where visual
myocardial contrast was observed even in ischemic regions
that were transiently equivalent to normally perfused terri-
tories (Fig. 1). Because of the reduced dynamic range, the
transient increase in microbubble concentration reaching
abnormally perfused segments after a bolus injection was
able to create a brief period of bright myocardial contrast
enhancement. Therefore, it is essential to have a period of at
least 5 s after the peak period of contrast enhancement
before any image interpretation and digital acquisition.
Furthermore, we consistently observed basal segment
attenuation with PID imaging at the low mechanical
index—a problem that may reduce the ability of this
technique to detect myocardial perfusion defects confined to
these segments. This phenomenon was observed with both
agents used in this study, but slightly more frequently with
the liposome-encapsulated agent. Continuous infusions, as
opposed to bolus injections, may reduce the far-field atten-
uation, as already observed with harmonic imaging (16).
The size and shell of microbubbles may also play a role in
the degree of attenuation observed, because more uniform
polymer-coated microbubbles have demonstrated less atten-
uation, as compared with Optison, which is albumin-coated
(17).
Conclusions and future directions. Pulse inversion Dopp-
ler imaging with a low mechanical index can be used to
analyze both myocardial perfusion and wall motion simul-
taneously during dobutamine stress echocardiography. The
advantages of PID imaging over harmonic imaging include
an absence of background signal and a higher signal to noise
ratio. Angiographically significant coronary artery stenoses
were detected with PID imaging; these would have been
considered normal on the basis of wall motion analysis
alone. However, because not all patients had angiography in
our study, we cannot assess the actual sensitivity and
specificity of PID imaging. A multicenter study is needed to
assess the feasibility of detecting myocardial perfusion de-
fects with PID imaging during dobutamine stress echocar-
diography, and whether it will significantly improve the
test’s sensitivity (without lowering specificity), as compared
with wall motion analysis.
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